About Cytecare
Cytecare is a Healthcare company based in Bengaluru (India) founded in 2014 by Suresh Ramu, Himanshu Shah, Ferzaan Engineer, and Anthony Pais, and was acquired by Omega Hospitals in November 2025. Oncology hospitals chain offering specialized cancer treatments. Cytecare has raised $78.45 million across 6 funding rounds from investors including Goldman Sachs, Omega Hospitals and Cytespace Research. The company has 256 employees. Cytecare was last valued at $34.1 million in July 2022. Its chief executive, as recorded, is Suresh Ramu. Its website cytecare.com draws about 15 thousand monthly visits. Its Indian entity Cytecare Hospitals Private Limited reported revenue of ₹93.10 Cr. Its focus areas include Hospital Chains, Single Specialty Hospital Chains and Oncology. Its competitors include HCG, Omega Hospitals and CION Cancer Clinics; 3 of its 3 listed competitors have raised funding.
Company details
Chain of oncology hospitals. It specializes in a wide range of cancer treatments, including advanced surgical care, Pediatric, Interventional, Uro Neuro oncology, Bone Marrow transplant, Gastrointestinal Cancer Treatment, Pain and Palliative Care, chemotherapy, ENT care, radiotherapy, Organ-Site Focused Care, Holistic Patient Support, Advanced Diagnostic Services, and more.
- Headquarters Bengaluru, India
- Employees 256
- Founders Suresh Ramu, Himanshu Shah, Ferzaan Engineer, Anthony Pais
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cytecare.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Omega Hospitals (Nov 2025)
- Legal Name Cytecare Hospitals Private Limited
- Date of Incorporation 11 Mar, 2014
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹93.10 Cr
FY 2024 · +19% YoY
- Net Loss-₹15.06 Cr
FY 2024 · -16% margin
- EBITDA-₹5.31 Cr
FY 2024 · -6% margin
- Total Equity Funding$78.45M (USD)
in 6 rounds
- Latest Funding Round$1.89M (USD), Series B
Jul 2022
- InvestorsGoldman Sachs
& 42 more
- Employee Count256
- Acquired byOmega Hospitals
(Nov 2025)
Associated legal entities of Cytecare
Cytecare operates through Cytecare Hospitals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cytecare Hospitals Private Limited CIN U85110GJ2014PTC079078 | Active | 11 Mar 2014 | Ahmedabad, Gujarat | ₹93.1 Cr | 256 | 3 | View details |
Apps and channels of Cytecare
its YouTube channel Cytecare Hospitals has 1.92K subscribers and 30 videos.
Videos from Cytecare
The most watched videos on Cytecare's YouTube channel, Cytecare Hospitals (1.92K subscribers). Click a video to play it here.
More on Cytecare Hospitals.
Funding Insights of Cytecare
Cytecare has successfully raised a total of $78.45M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.89 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $78.45M
- Total Rounds 6
- Last Round Series B — $1.89M
- First Round $14.16M
(May 2014)
- Investors Count 42
All 6 funding rounds of Cytecare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $1.89M | Series B | $34.1M | Canadian International Health Education Association | – |
| Nov 2020 | $2.72M | Series B | $34M | Cytespace Research | |
| Jul 2019 | $4.01M | Series B | $••••• | Goldman Sachs, Gi Global Health | |
| May 2018 | $31M | Series A | $••••• | Goldman Sachs | – |
| May 2016 | $24.67M | Series A | $••••• | Gi Global Health | |
| May 2014 | $14.16M | Series A | – | Corvest Investment, Gi Global Health |
| Date | Valuation | Stage |
|---|---|---|
| Jul 2022 | $34.1M | •••••••• |
| Nov 2020 | $34M | •••••••• |
| Jul 2019 | $••••• | •••••••• |
| May 2018 | $••••• | •••••••• |
| May 2016 | $••••• | •••••••• |
| May 2014 | $••••• | •••••••• |
Full valuation and stage history of Cytecare
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $34.1M (Jul 2022). 43 investors in total: 16 institutional and 27 angel.
Investors in Cytecare
Cytecare has secured backing from 43 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Goldman Sachs, Omega Hospitals and Cytespace Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Venture capital is provided to tech startups by the fund. | antelopesummitinvestments.tcc.mode | Road Town, British Virgin Islands | ||
Seed-stage investments are targeted by Jacesa Investments venture capital firm. | jacesainvestments.tcc.mode | Zug, Switzerland | ||
Healthcare sectors are targeted by Oikos Asia Healthcare investments. | oikosasiahealthcare.tcc.mode | Hong Kong, China | ||
Growth equity is provided by a sector-agnostic private equity firm. | endeavour.investments | Belfast, United Kingdom | ||
Operates as a Non-Banking Financial Company offering business loans. | 1989 | shanghvifinance.com | Mumbai, India | |
Site-solutions organization offering its services in India, Africa and Singapore | 2011 | cytespace.com | Bengaluru, India | |
NRG Oncology is focused on cancer research through clinical trials. | nrgoncology.org | Philadelphia, United States | ||
| giglobalhealthfund.tcc.mode | ||||
| giglobalhealth.tcc.mode |
Investor details for Cytecare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cytecare Hospitals Private Limited (Cytecare)
Cytecare Hospitals Private Limited is the primary company behind Cytecare. The board of Cytecare Hospitals Private Limited currently have 3 directors; the longest-serving is Ferzaan Nariman Engineer, appointed in 2014. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ferzaan Nariman Engineer DIN 00025758 | Director | 15 Jun 2014 | 12 yrs 4 mo | Cytecare Hospitals Private Limited |
| Mohan Vamsy Chigurupati DIN 02991799 | Additional Director | 03 Nov 2025 | 11 mo | Cytecare Hospitals Private Limited |
| Padmaja Chigurupati DIN 03019601 | Additional Director | 03 Nov 2025 | 11 mo | Cytecare Hospitals Private Limited |
People of Cytecare
24 people are tracked at Cytecare (9 in leadership, 9 in board & advisors, 6 in team); the tracked headcount is 256.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder & Director | Leadership | |
| Co-Founder | Leadership | |
Anthony Pais | Co-Founder | Leadership |
Amit Sharma | Chief Information Officer & Head Partnerships & CSR | Leadership |
Rekha Shivakumar | Head, Patient Services & Experience | Leadership |
Ganapati Dattatreya Hegde | Head of International Business | Leadership |
Jai Mani | CMO | Leadership |
Raj Sarvottam | CFO | Leadership |
Gillian Corken | Board Member | Board & advisors |
John Goodacre | Board Member | Board & advisors |
Ravi Achar | Board Member | Board & advisors |
Vishal Bali | Board Member | Board & advisors |
Shikhar Dharamsey | Board Member | Board & advisors |
Oppel Greeff | Board Member | Board & advisors |
Naren Ramakrishna | Advisor | Board & advisors |
Gerardus Hoogland | Board Member | Board & advisors |
Ajit Rampure | Board Member | Board & advisors |
Dr Nandini Shadaksharaiah | Manager Patient Services | Team |
Dhananjay Katti | Marketing Manager | Team |
4 more people are available in the full profile.
Complete people profiles for Cytecare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cytecare
Figures of Cytecare Hospitals Private Limited, the primary company behind Cytecare, for FY 2024. Revenue was ₹93.10 Cr (+19% year on year). Net loss was -₹15.06 Cr (-16% margin). EBITDA was -₹5.31 Cr (-6% margin). Revenue has grown at a compounded annual rate of +21% over three years and +19% over five years.
- ₹93.10 CrRevenue · FY 2024 · +19% YoY
- -₹15.06 CrNet loss · -16% margin
- -₹5.31 CrEBITDA · -6% margin
- ₹48.6 LakhPaid-up capital
- 256Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cytecare Hospitals Private Limited are on its company page.
Detailed financial statements for Cytecare
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cytecare
5 dated milestones of Cytecare across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Cytecare is founded.
- Funding First funding round of $14.2M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $1.9M.
- Exit Acquired by Omega Hospitals.
Competitors of Cytecare
Cytecare has 3 listed competitors in our database, 3 of them funded. They include HCG, Omega Hospitals and CION Cancer Clinics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hcgoncology.com | 1989 | Bengaluru, India | $36.59M | 3,273 | Chain of oncology hospitals | |
| omegahospitals.com | 2010 | Hyderabad, India | $59.94M | 1,101 | Specialized oncology treatments are offered by a hospital chain. | |
| cioncancerclinics.com | 2019 | Hyderabad, India | $10.87M | 119 | Cancer treatments and support are provided by a clinic chain. |
Detailed competitors of Cytecare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cytecare
The website of Cytecare (cytecare.com) receives about 15.2K visits a month.
- Monthly visits15.2K
Websites whose visitors overlap most with Cytecare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
migrainepal.com | migrainepal.com | 100% | #6,962,325 | – | |
| nephroplus.com | 89% | 25.4K | #869,243 | View details | |
targetedonc.com | targetedonc.com | 74% | #379,902 | – | |
nationalbreastcancer.org | nationalbreastcancer.org | 74% | #254,687 | – | |
breastcancer.org | breastcancer.org | 74% | #118,297 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Cytecare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Cytecare (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 8,400 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cytecare
Complete news archive for Cytecare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytecare
Cytecare was founded in 2014.
Cytecare is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Suresh Ramu is the CEO of Cytecare, as recorded in our data. They have also founded this company.
Cytecare is a funded company, having raised a total of $78.45M across 6 funding rounds to date. The company's 1st funding round was a Series A of $14.16M, raised on May 2014.
Cytecare has 256 employees.
The primary company behind Cytecare, Cytecare Hospitals Private Limited, reported revenue of ₹93.10 Cr for FY 2024, up 19% year on year.
Chain of oncology hospitals. It specializes in a wide range of cancer treatments, including advanced surgical care, Pediatric, Interventional, Uro Neuro oncology, Bone Marrow transplant, Gastrointestinal Cancer Treatment, Pain and Palliative Care, chemotherapy, ENT care, radiotherapy, Organ-Site Focused Care, Holistic Patient Support, Advanced Diagnostic Services, and more.
Cytecare's top competitors include HCG, CION Cancer Clinics and Omega Hospitals.
Cytecare has 43 investors. Key investors include Goldman Sachs, Omega Hospitals, Cytespace Research, Shanghvi Finance, and Synergy AG.
The valuation of Cytecare is $34.1M as of Jul 2022.
Cytecare operates through Cytecare Hospitals Private Limited.
Yes. Cytecare was acquired by Omega Hospitals in November 2025.